Supplementary Table S2 from IL2 Targeted to CD8<sup>+</sup> T Cells Promotes Robust Effector T-cell Responses and Potent Antitumor Immunity
Kelly D. Moynihan(Ragon Institute of MGH, MIT and Harvard), Ivana M. Djuretic
Cited by 0
Related Papers
Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses
|Nature Medicine|2016|536
Cell and fluid sampling microneedle patches for monitoring skin-resident immunity
|Science Translational Medicine|2018|158
An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor Immunity
|Cancer Immunology Research|2021|98